Efficacy and safety of intra-arterial thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis

被引:0
作者
Lele Huang
Yujie Wang
Ruijun Zhang
机构
[1] The First Affiliated Hospital of China Medical University,Department of Ophthalmology
[2] People’s Hospital of Liaoning Province,Department of Neurology
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2023年 / 261卷
关键词
Central retinal artery occlusion; Intra-arterial thrombolysis; Visual acuity; Adverse effects; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:103 / 113
页数:10
相关论文
共 130 条
  • [1] Leavitt JA(2011)The incidence of central retinal artery occlusion in Olmsted County, Minnesota Am J Ophthalmol 152 820-823
  • [2] Larson TA(2014)Nationwide incidence of clinically diagnosed central retinal artery occlusion in Korea, 2008 to 2011 Ophthalmology 121 1933-1938
  • [3] Hodge DO(2020)Nationwide incidence of central retinal artery occlusion in Japan: an exploratory descriptive study using the National Database of Health Insurance Claims (2011–2015) BMJ Open 24 e041104-695
  • [4] Gullerud RE(2020)Thrombolytic therapy for acute central retinal artery occlusion Stroke 51 687-1154
  • [5] Park SJ(2015)Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis JAMA Neurol 72 1148-345
  • [6] Choi NK(2020)Thrombolysis for central retinal artery occlusion in 2020: time is vision! J Neuroophthalmol 40 333-e294
  • [7] Seo KH(2021)Management of central retinal artery occlusion: a scientific statement from the American Heart Association Stroke 52 e282-287
  • [8] Park KH(2020)Retinal and ophthalmic artery occlusions preferred practice pattern® Ophthalmology 127 259-2025
  • [9] Woo SJ(2020)Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis Stroke 51 2018-916
  • [10] Kido A(2000)Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data Br J Ophthalmol 84 914-1375